Dr. Yao and colleagues reply

New England Journal of Medicine

Volumn 364, Issue 19, 2011, Pages 1874-1875

  Yao, James C ^a   Ito, Tetsuhide ^b   Öberg, Kjell ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b KYUSHU UNIVERSITY   (Japan)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; GLUCAGON; GLUCOSE; PLACEBO; STREPTOZOCIN;

DIABETES MELLITUS; GLUCAGON BLOOD LEVEL; GLUCAGONOMA; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULINOMA; LETTER; MULTIPLE CYCLE TREATMENT; NEUROENDOCRINE TUMOR; PANCREAS RESECTION; PANCREAS TUMOR; PRIORITY JOURNAL;

EID: 79955907839     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Yao JC, Rindi G, Evans DB. Pancreatic endocrine tumors. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. Cancer: principles & practice of oncology. 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2008:1702-21.
2. Kulke MH, Bergsland EK, Yao JC. Glycemic control in patients with insulinoma treated with everolimus. N Engl J Med 2009;360:195-7.